基于预配方策略的热挤压固体分散的制备及其增强的治疗效率
Seon-Kwang Lee1, Eun-Sol Ha1, Heejun Park2
1College of Pharmacy, Pusan National University, 63 Busandaehak-ro, Geumjeong-gu, Busan 46241, Republic of Korea.
Pharmaceutics
|December 23, 2023
概括
这项研究使用热挤出开发了bisacodyl的无形固体分散,增强了其治疗功效. 基甲基纤维素 (HPMC) 配方在子中表现出优越的物理稳定性和体内松作用.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 比萨科迪尔是一种水溶性较差的药物,限制了其治疗功效.
- 无形固体分散 (ASDs) 可以增强难溶性药物的可溶性和生物利用性.
研究的目的:
- 用热挤出方法制备和描述bisacodyl的无形固体分散物.
- 调查药物聚合物混合性和相互作用,以开发最佳配方.
- 评估开发的bisacodyl ASDs的体外和体内性能.
主要方法:
- 汉森溶解度参数计算和差异扫描热量计 (DSC) 用于混合性评估.
- 动态蒸汽吸附 (DVS),富里叶变换红外光谱 (FT-IR) 和拉曼光谱用于药物聚合物相互作用分析.
- 在便引起的子中进行非水槽溶解试验和体内研究,以评估治疗疗效.
主要成果:
- 证实了bisacodyl和聚合物之间的混合性,其中基甲基纤维素 (HPMC) 显示出优越的物理稳定性和抗沉效应.
- HPMC-bisacodyl ASDs在体外溶解中表现出显著改善的溶解概况.
- 与原始bisacodyl相比,含有HPMC-bisacodyl的肠涂片显示在体内增强了便疗效.
结论:
- 预制策略有效指导了对比萨科迪尔ASDs适合的聚合物的选择.
- 热挤出是一种可行的方法,可以生产稳定有效的bisacodyl ASDs.
- 开发的HPMC-bisacodyl ASDs为治疗便秘提供了更好的治疗潜力.
更多相关视频
11:27A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
2.1K
10:36Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
Published on: December 9, 2022
6.9K
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Recrystallization: Solid–Solution Equilibria
1.1K
Recrystallization is a purification technique used to separate impurities from solid compounds. In this technique, no chemical reactions occur. Instead, it exploits physical properties only, specifically, the solubility differences between the desired compound and impurities, either at a single temperature or at different temperatures, and under other selected conditions. The solid-solution equilibrium (solubility equilibrium) of each component in the solution represents a binary phase...
1.1K
